News + Filings Transactions Holdings
|
Rock Springs Capital Management LP
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
Blueprint Medicines Corp
| BPMC | COM | 2,186,672 | 153,624 | 138,197,670,000 | 46,730,840,000 | 3.29 | |
Hist
| 06/30/2023 |
Immunocore Holdings plc
| IMCR | Common | 3,028,410 | 26,748 | 181,583,464,000 | 33,181,295,000 | 4.32 | |
Hist
| 06/30/2023 |
Abcam plc
| ABCM | Common | 2,405,000 | 162,500 | 58,850,350,000 | 28,666,300,000 | 1.40 | 1.05 |
Hist
| 06/30/2023 |
EXACT SCIENCES CORP
| EXAS | Common | 943,500 | 2,000 | 88,594,650,000 | 24,751,535,000 | 2.11 | 0.52 |
Hist
| 06/30/2023 |
Akero Therapeutics, Inc.
| AKRO | Common | 1,550,754 | 96,500 | 72,404,704,000 | 16,764,946,000 | 1.72 | 3.10 |
Hist
| 06/30/2023 |
AGIOS PHARMACEUTICALS, INC.
| AGIO | Common | 2,686,167 | 24,562 | 76,072,249,000 | 14,935,182,000 | 1.81 | 4.83 |
Hist
| 06/30/2023 |
Immatics N.V.
| IMTX | Common | 2,536,144 | 22,221 | 29,267,102,000 | 11,921,033,000 | 0.70 | 3.31 |
Hist
| 06/30/2023 |
Ultragenyx Pharmaceutical Inc.
| RARE | COM | 1,384,269 | 47,868 | 63,856,329,000 | 10,266,649,000 | 1.52 | |
Hist
| 06/30/2023 |
Acadia Healthcare Company, Inc.
| ACHC | COM | 908,000 | 47,132 | 72,313,120,000 | 10,115,407,000 | 1.72 | |
Hist
| 06/30/2023 |
Disc Medicine, Inc.
| IRON | Common | 363,468 | 50,000 | 16,137,979,000 | 9,495,592,000 | 0.38 | 1.84 |
Hist
| 06/30/2023 |
MIRENCO INC
| MREO | Common | 7,042,391 | 797,494 | 9,295,956,000 | 4,881,438,000 | 0.22 | |
Hist
| 06/30/2023 |
Mirum Pharmaceuticals, Inc.
| MIRM | Common | 1,820,733 | 25,000 | 47,102,363,000 | 3,968,856,000 | 1.12 | 4.79 |
Hist
| 06/30/2023 |
Icosavax, Inc.
| ICVX | Common | 868,409 | 3,899 | 8,623,301,000 | 3,609,143,000 | 0.21 | 2.10 |
Hist
| 06/30/2023 |
HUMANA INC
| HUM | Common | 470,000 | 43,500 | 210,151,100,000 | 3,102,410,000 | 5.00 | |
Hist
| 06/30/2023 |
Azenta, Inc.
| BRKS | Common | 469,900 | 38,700 | 21,934,932,000 | 2,694,788,000 | 0.52 | 0.72 |
Hist
| 06/30/2023 |
Warby Parker Inc.
| WRBY | Common | 1,325,000 | 25,000 | 15,489,250,000 | 1,722,250,000 | 0.37 | |
Hist
| 06/30/2023 |
Accolade, Inc.
| | Common | 2,820,000 | 275,000 | 37,985,400,000 | 1,388,300,000 | 0.90 | 3.73 |
Hist
| 06/30/2023 |
Mirati Therapeutics, Inc.
| MRTX | COM | 1,121,647 | 56,386 | 40,525,106,000 | 918,702,000 | 0.96 | 1.93 |
Hist
| 06/30/2023 |
Inozyme Pharma, Inc.
| INZY | Common | 3,428,084 | 213,184 | 19,094,428,000 | 673,051,000 | 0.45 | 7.78 |
Hist
| 06/30/2023 |
NOVAVAX INC
| NVAX | COMMON | 536,700 | 1,300 | 3,987,681,000 | 277,359,000 | 0.09 | 0.62 |
Hist
| 06/30/2023 |
ESSA Pharma Inc.
| EPIX | COM NEW | 663,317 | 138,373 | 1,790,956,000 | 231,872,000 | 0.04 | 1.50 |
Hist
| 06/30/2023 |
EDAP TMS SA
| EDAP | SPONSORED ADR | 1,186,300 | 156,300 | 10,937,686,000 | -464,414,000 | 0.26 | |
Hist
| 06/30/2023 |
Pacira BioSciences, Inc.
| PCRX | Common | 1,035,000 | 2,400 | 41,472,450,000 | -667,956,000 | 0.99 | 2.25 |
Hist
| 06/30/2023 |
Celldex Therapeutics, Inc.
| CLDX | COMMON | 421,615 | 111 | 14,305,397,000 | -860,317,000 | 0.34 | |
Hist
| 06/30/2023 |
Zai Lab Ltd
| ZLAB | Common | 1,222,423 | 162,723 | 33,897,790,000 | -1,347,832,000 | 0.81 | |
Hist
| 06/30/2023 |
Phreesia, Inc.
| PHR | Common | 1,305,000 | 2,500 | 40,468,050,000 | -1,589,675,000 | 0.96 | 2.43 |
Hist
| 06/30/2023 |
NEUROCRINE BIOSCIENCES INC
| NBIX | Common | 1,279,500 | 69,400 | 120,656,850,000 | -1,829,472,000 | 2.87 | 1.32 |
Hist
| 06/30/2023 |
BIOCRYST PHARMACEUTICALS INC
| BCRX | Common | 2,497,193 | 163,108 | 17,580,239,000 | -1,886,030,000 | 0.42 | 1.32 |
Hist
| 06/30/2023 |
Kymera Therapeutics, Inc.
| KYMR | Common | 1,487,551 | 259,172 | 34,198,797,000 | -2,198,073,000 | 0.81 | 2.70 |
Hist
| 06/30/2023 |
Travere Therapeutics, Inc.
| TVTX | Common | 1,527,720 | 251,070 | 23,465,779,000 | -5,246,080,000 | 0.56 | 2.36 |
Hist
| 06/30/2023 |
Olink Holding AB (publ)
| OLK | SPONSORED ADS | 1,654,000 | 4,000 | 31,012,500,000 | -6,162,000,000 | 0.74 | |
Hist
| 06/30/2023 |
NEVRO CORP
| NVRO | Common | 1,211,400 | 133,500 | 30,793,788,000 | -8,172,297,000 | 0.73 | |
Hist
| 06/30/2023 |
Amylyx Pharmaceuticals, Inc.
| AMLX | Common | 1,544,616 | 91,800 | 33,317,367,000 | -9,308,254,000 | 0.79 | 2.30 |
Hist
| 06/30/2023 |
INSULET CORP
| PODD | Common | 559,000 | 22,250 | 161,182,060,000 | -10,019,720,000 | 3.83 | |
Hist
| 06/30/2023 |
agilon health, inc.
| AGL | COM | 8,282,500 | 400,000 | 143,618,550,000 | -43,590,825,000 | 3.42 | 2.00 |
Hist
| 06/30/2023 |
|
|
|
|